Introduction
Using a variety of genetic techniques, the laboratory of Paul M. Lieberman, Ph.D., is studying how certain viruses remain in a latent stage in host immune cells, and more importantly what biochemical pathways spark the virus to awaken and replicate. The viruses studied include Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus.
Wistar Receives $4.7 M to Fight Cancers Caused by EBV
The Seeding Drug Discovery Award will support Dr. Lieberman's translational research.
Read more>